MedPath

Terconazole

Terconazole Vaginal Cream 0.4%

Approved
Approval ID

b922feb5-cd85-4f13-9a18-913e58f8da83

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 9, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terconazole

PRODUCT DETAILS

NDC Product Code50090-0917
Application NumberANDA076043
Marketing CategoryC73584
Route of AdministrationVAGINAL
Effective DateNovember 7, 2019
Generic NameTerconazole

INGREDIENTS (9)

TERCONAZOLEActive
Quantity: 4 mg in 1 g
Code: 0KJ2VE664U
Classification: ACTIB
butylated hydroxyanisoleInactive
Code: REK4960K2U
Classification: IACT
isopropyl myristateInactive
Code: 0RE8K4LNJS
Classification: IACT
cetyl alcoholInactive
Code: 936JST6JCN
Classification: IACT
polysorbate 60Inactive
Code: CAL22UVI4M
Classification: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
stearyl alcoholInactive
Code: 2KR89I4H1Y
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Terconazole - FDA Drug Approval Details